http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18764319

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 1220
issn 0149-2918
issueIdentifier 6
pageRange 1209-1220
publicationName Clinical Therapeutics
startingPage 1209
bibliographicCitation Cheng JW. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes. Clin Ther. 2012 Jun;34(6):1209–20. doi: 10.1016/j.clinthera.2012.04.005. PMID: 22521881.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa869843c467955ba8bdedaa08c23f66
date 201206
identifier https://doi.org/10.1016/j.clinthera.2012.04.005
https://pubmed.ncbi.nlm.nih.gov/22521881
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2822
https://portal.issn.org/resource/ISSN/0149-2918
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes
discusses http://id.nlm.nih.gov/mesh/M0000377
http://id.nlm.nih.gov/mesh/M0545377
http://id.nlm.nih.gov/mesh/M0513890
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D054058Q000188
http://id.nlm.nih.gov/mesh/D058921Q000627
http://id.nlm.nih.gov/mesh/D000241Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000241Q000009
http://id.nlm.nih.gov/mesh/D000241Q000627
http://id.nlm.nih.gov/mesh/D000241Q000008
http://id.nlm.nih.gov/mesh/D058921Q000008
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D058921Q000009
http://id.nlm.nih.gov/mesh/D000241Q000494
http://id.nlm.nih.gov/mesh/D000077486
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D058921Q000494
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10545
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7090
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247988848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075

Total number of triples: 56.